Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000886163-24-000071
Filing Date
2024-08-07
Accepted
2024-08-07 16:30:54
Documents
83
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q lgnd-20240630.htm   iXBRL 10-Q 1337509
2 EX-2.1 exhibit21apeironbiologicsa.htm EX-2.1 543348
3 EX-10.1 exhibit101_ligand-firstame.htm EX-10.1 86293
4 EX-10.2 exhibit102_ligand-agenusxp.htm EX-10.2 713342
5 EX-31.1 lgnd_63024exhibit311.htm EX-31.1 15159
6 EX-31.2 lgnd_63024exhibit312.htm EX-31.2 15429
7 EX-32.1 lgnd_63024exhibit321.htm EX-32.1 11158
13 image_0a.jpg GRAPHIC 117
14 image_2a.jpg GRAPHIC 90146
15 image_6a.jpg GRAPHIC 2642
16 lgnd-20240630_g1.jpg GRAPHIC 43732
  Complete submission text file 0000886163-24-000071.txt   10488144

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lgnd-20240630.xsd EX-101.SCH 63651
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lgnd-20240630_cal.xml EX-101.CAL 101827
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lgnd-20240630_def.xml EX-101.DEF 385134
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lgnd-20240630_lab.xml EX-101.LAB 846651
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lgnd-20240630_pre.xml EX-101.PRE 611133
85 EXTRACTED XBRL INSTANCE DOCUMENT lgnd-20240630_htm.xml XML 1194291
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33093 | Film No.: 241184326
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)